Inactive Instrument

NPS Pharmaceuticals, Inc. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
2015	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	15-02-12	RE
NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	15-01-26	RE
Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	15-01-14	RE
Alcoa : Wall St. falls; energy shares dragged down further by oil	15-01-12	RE
AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg	14-12-17	RE
NPS Pharmaceuticals : Shire secures $5 billion funding for NPS Pharma bid - The Times	14-06-01	RE

NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma	15-02-21	PR
NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis	15-02-06	PR
NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism	15-01-23	BU
NPS Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of NPS Pharmaceuticals, Inc.	15-01-13	PR
NPS Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NPS Pharmaceuticals, Inc. Stockholders	15-01-12	BU

American Airlines : Les valeurs à suivre sur les marchés américains	15-01-26
Foundation Medicine : Wall Street clôture en baisse avec le pétrole	15-01-12
Alcoa : Wall Street ouvre en recul avant la saison des résultats	15-01-12
Alcoa : Les valeurs à suivre sur les marchés américains	15-01-12
Shire acquiert la biotech NPS Pharma pour $5,2 mds	15-01-11

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-3.13%	103B
REGENERON PHARMACEUTICALS, INC.	+1.80%	96.56B
ARGENX SE	+1.72%	22.61B
BIONTECH SE	-18.19%	21.18B
GENMAB A/S	-4.50%	19.07B
WUXI APPTEC CO., LTD.	-41.75%	16.53B
BEIGENE, LTD.	-25.68%	14.46B
NEUROCRINE BIOSCIENCES, INC.	+0.93%	13.25B
SAREPTA THERAPEUTICS, INC.	+21.63%	11.1B